Skip to content

Clinical trials

Phase 3 Urinary Bladder, Overactive trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder, Overactive Phase: Phase 3 Country / region: United Kingdom Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20061
20071
20082
20092
20101
20123
20133
20141
20161
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan6
Astellas Pharma Europe B.V.4
Astellas Pharma Inc4
Astellas Pharma Europe Ltd.2
Astellas Pharma Global Development, Inc.1
Ipsen1
Jazz Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder, Overactive19
Urinary Incontinence9
Nocturia2
Urinary Bladder Diseases2
Urinary Incontinence, Urge2
Urologic Diseases2
Multiple Sclerosis1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.